Table 1.
Patient clinical characteristics
| Variable | n (%) |
|---|---|
| Age (y) | |
| Median (range) |
75 (38-100) |
| Gender | |
| Male |
79 (59) |
| Female |
54 (41) |
| PS | |
| 3 |
103 (77) |
| 4 |
30 (23) |
| Concomitant disease associated with worsening PS | |
| Yes |
19 (14) |
| No |
114 (86) |
| Primary site | |
| Lung |
51 (38) |
| Stomach |
8 (6) |
| Esophagus |
8 (6) |
| Bladder |
8 (6) |
| Breast |
7 (5) |
| Colorectum |
7 (5) |
| Prostate |
7 (5) |
| Liver |
6 (5) |
| Other |
31 (23) |
| No. of metastatic lesion | |
| 0-3 |
30 (23) |
| ≧ 4 |
103 (77) |
| Histology | |
| Squamous cell carcinoma |
30 (23) |
| Adenocarcinoma |
35 (26) |
| Small cell carcinoma |
15 (11) |
| Hepatocellular carcinoma |
6 (5) |
| Transitional cell carcinoma |
6 (5) |
| Other |
41 (31) |
| No. of irradiated site | |
| One site |
117 (88) |
| Two sites |
15 (11) |
| Three sites |
1 (1) |
| Irradiated site (n = 150) | |
| Primary tumor | |
| Bladder |
7 (5) |
| Lung |
7 (5) |
| Esophagus |
5 (3) |
| Uterus |
3 (2) |
| Rectum |
3 (2) |
| Others |
9 (6) |
| Metastatic tumor | |
| Bone |
86 (57) |
| Vertebrate |
47 |
| Pelvic |
17 |
| Rib |
10 |
| Femur |
4 |
| Others |
8 |
| Brain |
18 (12) |
| Mediastinum |
5 (3) |
| Head and neck |
3 (2) |
| Others | 4 (3) |